159 related articles for article (PubMed ID: 9761676)
21. Crystal structure of the disulfide-stabilized Fv fragment of anticancer antibody B1: conformational influence of an engineered disulfide bond.
Almog O; Benhar I; Vasmatzis G; Tordova M; Lee B; Pastan I; Gilliland GL
Proteins; 1998 May; 31(2):128-38. PubMed ID: 9593187
[TBL] [Abstract][Full Text] [Related]
22. An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly.
Wörn A; Plückthun A
FEBS Lett; 1998 May; 427(3):357-61. PubMed ID: 9637257
[TBL] [Abstract][Full Text] [Related]
23. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
Wang Y; Li X; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
[TBL] [Abstract][Full Text] [Related]
24. Rapid expression of vaccine proteins for B-cell lymphoma in a cell-free system.
Yang J; Kanter G; Voloshin A; Michel-Reydellet N; Velkeen H; Levy R; Swartz JR
Biotechnol Bioeng; 2005 Mar; 89(5):503-11. PubMed ID: 15669088
[TBL] [Abstract][Full Text] [Related]
25. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.
Yang X; Hu W; Li F; Xia H; Zhang Z
Protein Expr Purif; 2005 Jun; 41(2):341-8. PubMed ID: 15866720
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of the anti-His tag antibody 3D5 single-chain fragment complexed to its antigen.
Kaufmann M; Lindner P; Honegger A; Blank K; Tschopp M; Capitani G; Plückthun A; Grütter MG
J Mol Biol; 2002 Apr; 318(1):135-47. PubMed ID: 12054774
[TBL] [Abstract][Full Text] [Related]
27. The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains.
Honegger A; Malebranche AD; Röthlisberger D; Plückthun A
Protein Eng Des Sel; 2009 Mar; 22(3):121-34. PubMed ID: 19136675
[TBL] [Abstract][Full Text] [Related]
28. Structural patterns at residue positions 9, 18, 67 and 82 in the VH framework regions of human and murine immunoglobulins.
Saul FA; Poljak RJ
J Mol Biol; 1993 Mar; 230(1):15-20. PubMed ID: 8450531
[TBL] [Abstract][Full Text] [Related]
29. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
[TBL] [Abstract][Full Text] [Related]
30. Removal of the conserved disulfide bridges from the scFv fragment of an antibody: effects on folding kinetics and aggregation.
Ramm K; Gehrig P; Plückthun A
J Mol Biol; 1999 Jul; 290(2):535-46. PubMed ID: 10390351
[TBL] [Abstract][Full Text] [Related]
31. Recognition of DNA by VH and Fv domains of an IgG anti-poly(dC) antibody with a singly mutated VH domain.
O'Connor KC; Nguyen K; Stollar BD
J Mol Recognit; 2001; 14(1):18-28. PubMed ID: 11180559
[TBL] [Abstract][Full Text] [Related]
32. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
33. Disulfide linkage engineering for improving biophysical properties of human VH domains.
Kim DY; Kandalaft H; Ding W; Ryan S; van Faassen H; Hirama T; Foote SJ; MacKenzie R; Tanha J
Protein Eng Des Sel; 2012 Oct; 25(10):581-9. PubMed ID: 22942392
[TBL] [Abstract][Full Text] [Related]
34. Engineering antibodies for stability and efficient folding.
Honegger A
Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
[TBL] [Abstract][Full Text] [Related]
35. Structure of a non-camelized human M12-V(H) domain at 1.5A resolution.
Gaur RK
J Struct Biol; 2005 Oct; 152(1):84-9. PubMed ID: 16183303
[TBL] [Abstract][Full Text] [Related]
36. Orientation, positional, additivity, and oligomerization-state effects of interhelical ion pairs in alpha-helical coiled-coils.
Kohn WD; Kay CM; Hodges RS
J Mol Biol; 1998 Nov; 283(5):993-1012. PubMed ID: 9799639
[TBL] [Abstract][Full Text] [Related]
37. Crystal structure of a human VH: requirements for maintaining a monomeric fragment.
Dottorini T; Vaughan CK; Walsh MA; LoSurdo P; Sollazzo M
Biochemistry; 2004 Jan; 43(3):622-8. PubMed ID: 14730966
[TBL] [Abstract][Full Text] [Related]
38. X-ray crystallography reveals stringent conservation of protein fold after removal of the only disulfide bridge from a stabilized immunoglobulin variable domain.
Usón I; Bes MT; Sheldrick GM; Schneider TR; Hartsch T; Fritz HJ
Fold Des; 1997; 2(6):357-61. PubMed ID: 9427009
[TBL] [Abstract][Full Text] [Related]
39. Molecular and immunochemical characteristics of monoclonal and recombinant antibodies selective for the triazine herbicide simetryn and application to environmental analysis.
Nishi K; Ishiuchi M; Morimune K; Ohkawa H
J Agric Food Chem; 2005 Jun; 53(13):5096-104. PubMed ID: 15969481
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a novel modification to monoclonal antibodies: thioether cross-link of heavy and light chains.
Tous GI; Wei Z; Feng J; Bilbulian S; Bowen S; Smith J; Strouse R; McGeehan P; Casas-Finet J; Schenerman MA
Anal Chem; 2005 May; 77(9):2675-82. PubMed ID: 15859580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
